SIRT6 and arthropathy: Thus, targeted strategies that maintain or activate SIRT6 to promote the chondrocyte phenotype and maintain cartilage ECM integrity represent promising avenues for both post-traumatic and age-associated OA therapy as well as other diseases of the joint.